CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction

SUMMARY: BACKGROUND: Development and validation of a quantitative radiomic risk score (QuRiS) and associated nomogram (QuRNom) for early-stage non-small cell lung cancer (ES-NSCLC) that is prognostic of disease-free survival (DFS) and predictive of the added benefit of adjuvant chemotherapy (ACT) fo...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Lancet Digit Health
Prif Awduron: Vaidya, Pranjal, Bera, Kaustav, Gupta, Amit, Wang, Xiangxue, Corredor, Germán, Fu, Pingfu, Beig, Niha, Prasanna, Prateek, Patil, Pradnya, Velu, Priya, Rajiah, Prabhakar, Gilkeson, Robert, Feldman, Michael, Choi, Humberto, Velcheti, Vamsidhar, Madabhushi, Anant
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7051021/
https://ncbi.nlm.nih.gov/pubmed/32123864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/s2589-7500(20)30002-9
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg